Cargando…
Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine
On March 16, 2020, Ukraine's Ministry of Health issued nonspecific interim guidance to continue enrolling patients in opioid agonist therapies (OAT) and transition existing patients to take-home dosing to reduce community COVID-19 transmission. Though the number of OAT patients increased modest...
Autores principales: | Meteliuk, Anna, Galvez de Leon, Samy J., Madden, Lynn M., Pykalo, Iryna, Fomenko, Tatiana, Filippovych, Myroslava, Farnum, Scott O., Dvoryak, Sergii, Islam, Zahedul M., Altice, Frederick L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769928/ https://www.ncbi.nlm.nih.gov/pubmed/33191004 http://dx.doi.org/10.1016/j.jsat.2020.108164 |
Ejemplares similares
-
Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west
por: Ivasiy, Roman, et al.
Publicado: (2023) -
Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine
por: Altice, Frederick L, et al.
Publicado: (2022) -
Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial
por: Pashchenko, Oleksandra, et al.
Publicado: (2022) -
Medications for opioid use disorder during war in Ukraine: Innovations in public and private clinic cooperation
por: Bromberg, Daniel J., et al.
Publicado: (2022) -
“Medications for opioid use disorder during the war in Ukraine: a more comprehensive view on the government response—Authors’ reply”
por: Bromberg, Daniel J., et al.
Publicado: (2023)